Regeneron Pharmaceuticals reported total assets of $41.73B and total liabilities of $10.02B for the quarter ended Jun 2026, up 9.2% year over year. This balance sheet covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Jun2009 | Sep2009 | Dec2009 | Mar2010 | Jun2010 | Sep2010 | Dec2010 | Mar2011 | Jun2011 | Sep2011 | Dec2011 | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 3,432.40M | 2,885.60M | 3,345.70M | 3,395.10M | 3,491.30M | 3,105.90M | 3,916.30M | 1,937.20M | 2,152.30M | 2,730.00M | 2,602.00M | 1,920.70M | 2,011.80M | 2,488.20M | 3,090.20M | 1,995.80M | 2,506.40M | 3,118.10M | 2,962.60M | 2,455.80M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Short-term InvestmentsInvestments (Current) | 2,355.20M | 2,809.10M | 3,704.90M | 4,171.30M | 3,530.40M | 4,636.40M | 5,043.40M | 6,990.50M | 7,761.30M | 8,114.80M | 7,917.50M | 7,888.30M | 7,784.70M | 6,524.30M | 5,259.20M | 5,473.80M | 5,937.20M | 5,487.10M | 5,791.10M | 5,538.80M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Current Investments | 5,787.60M | 5,694.70M | 7,050.60M | 7,566.40M | 7,021.70M | 7,742.30M | 8,959.70M | 8,927.70M | 9,913.60M | 10,844.80M | 10,519.50M | 9,809.00M | 9,796.50M | 9,012.50M | 8,349.40M | 7,469.60M | 8,443.60M | 8,605.20M | 8,753.70M | 7,994.60M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables - NetNet Receivables | 5,452.00M | 6,036.50M | 4,839.00M | 5,161.40M | 5,548.30M | 5,328.70M | 5,118.60M | 5,121.30M | 5,584.50M | 5,667.30M | 5,222.20M | 5,717.10M | 6,107.10M | 6,211.90M | 5,561.00M | 5,610.00M | 5,687.10M | 5,741.10M | 5,731.00M | 6,565.40M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables - OtherOther Receivables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | 5,452.00M | 6,036.50M | 4,839.00M | 5,161.40M | 5,548.30M | 5,328.70M | 5,118.60M | 5,121.30M | 5,584.50M | 5,667.30M | 5,222.20M | 5,717.10M | 6,107.10M | 6,211.90M | 5,561.00M | 5,610.00M | 5,687.10M | 5,741.10M | 5,731.00M | 6,565.40M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | 2,053.80M | 1,951.30M | 1,991.50M | 2,218.50M | 2,412.20M | 2,401.90M | 2,424.70M | 2,507.70M | 2,562.00M | 2,580.50M | 2,714.90M | 2,873.60M | 3,018.00M | 3,087.30M | 3,192.40M | 3,205.60M | 3,254.40M | 3,200.80M | 3,103.60M | 3,084.30M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Current Deferred Tax AssetsCurrent Deferred Tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid Assets | 482.00M | 332.40M | 424.90M | 583.60M | 446.40M | 411.20M | 406.20M | 366.30M | 574.70M | 386.60M | 414.90M | 681.90M | 412.00M | 349.20M | 468.90M | 574.30M | 595.60M | 474.80M | 620.90M | 801.70M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Current Assets | 13,775.40M | 14,014.90M | 14,306.00M | 15,529.90M | 15,428.60M | 15,884.10M | 16,909.20M | 16,923.00M | 18,634.80M | 19,479.20M | 18,871.50M | 19,081.60M | 19,333.60M | 18,660.90M | 17,571.70M | 16,859.50M | 17,980.70M | 18,021.90M | 18,209.20M | 18,446.00M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Buildings | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Construction in Progress | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 3,395.70M | 3,482.20M | 3,556.40M | 3,637.70M | 3,704.20M | 3,763.00M | 3,880.90M | 3,922.60M | 4,006.10M | 4,146.40M | 4,225.50M | 4,305.90M | 4,439.20M | 4,599.70M | 4,694.20M | 4,840.70M | 5,002.30M | 5,120.40M | 5,266.10M | 5,458.90M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Long-Term Investments | 5,631.30M | 6,838.00M | 7,084.00M | 6,415.90M | 5,968.60M | 6,591.80M | 6,066.60M | 6,327.20M | 5,778.50M | 5,396.50M | 6,978.80M | 7,722.40M | 8,490.90M | 8,900.10M | 9,276.30M | 10,058.20M | 10,285.70M | 10,260.60M | 9,786.00M | 9,828.30M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Intangibles | 6.70M | 915.50M | 915.50M | 928.70M | 953.00M | 1,017.20M | 1,038.60M | 1,058.70M | 1,102.20M | 1,120.10M | 1,148.60M | 1,167.00M | 1,351.70M | 1,380.90M | 1,257.40M | 1,286.90M | 1,309.80M | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill & Intangibles | 6.70M | 915.50M | 915.50M | 928.70M | 953.00M | 1,017.20M | 1,038.60M | 1,058.70M | 1,102.20M | 1,120.10M | 1,148.60M | 1,167.00M | 1,351.70M | 1,380.90M | 1,257.40M | 1,286.90M | 1,309.80M | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Long-Term Deferred Tax | 723.20M | 876.90M | 1,140.30M | 1,352.40M | 1,452.10M | 1,723.70M | 1,924.90M | 2,138.50M | 2,316.80M | 2,575.40M | 2,764.90M | 2,880.90M | 3,015.10M | 3,314.10M | 3,442.90M | 3,572.20M | 3,846.70M | 4,077.20M | 4,190.90M | 4,381.40M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other Non-Current Assets | 145.90M | 216.10M | 262.00M | 269.90M | 320.20M | 336.40M | 349.60M | 393.20M | 409.90M | 444.10M | 470.20M | 993.80M | 1,043.00M | 1,136.00M | 1,393.10M | 1,536.90M | 1,673.10M | 1,821.20M | 2,129.70M | 2,306.20M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Assets | 9,896.10M | 11,419.90M | 12,042.70M | 11,675.90M | 12,249.20M | 13,330.40M | 13,150.70M | 13,734.50M | 13,528.50M | 13,601.00M | 15,498.10M | 17,005.20M | 18,108.30M | 19,098.50M | 19,973.50M | 21,359.70M | 22,188.70M | 22,536.80M | 22,659.60M | 23,284.60M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | 23,671.50M | 25,434.80M | 26,348.70M | 27,205.80M | 27,677.80M | 29,214.50M | 30,059.90M | 30,657.50M | 32,163.30M | 33,080.20M | 34,369.60M | 36,086.80M | 37,441.90M | 37,759.40M | 37,545.20M | 38,219.20M | 40,169.40M | 40,558.70M | 40,868.80M | 41,730.60M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Payables | 427.00M | 564.00M | 470.30M | 534.20M | 535.60M | 589.20M | 599.50M | 547.30M | 536.60M | 606.60M | 671.30M | 561.70M | 497.30M | 789.50M | 705.50M | 723.90M | 903.80M | 939.00M | 1,027.10M | 1,159.30M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Notes Payables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Payables | 427.00M | 564.00M | 470.30M | 534.20M | 535.60M | 589.20M | 599.50M | 547.30M | 536.60M | 606.60M | 671.30M | 561.70M | 497.30M | 789.50M | 705.50M | 723.90M | 903.80M | 939.00M | 1,027.10M | 1,159.30M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Accumulated Expenses | 2,061.00M | 2,206.80M | 2,046.00M | 1,933.40M | 1,796.40M | 2,074.20M | 2,074.30M | 2,176.00M | 2,644.70M | 2,357.90M | 2,392.90M | 2,360.90M | 2,536.50M | 2,527.10M | 2,241.80M | 2,461.20M | 2,975.70M | 2,876.40M | 2,724.40M | 2,966.50M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other Accumulated Expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Leases | 719.00M | 719.70M | 720.00M | 720.00M | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Deferred Revenue | 507.80M | 442.00M | 491.30M | 566.30M | 547.20M | 477.90M | 426.30M | 381.10M | 417.30M | 458.90M | 516.70M | 586.00M | 627.20M | 627.70M | 619.30M | 481.90M | 545.60M | 553.00M | 636.20M | 684.80M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Current Liabilities | 3,714.80M | 3,932.50M | 3,007.60M | 3,033.90M | 2,879.20M | 3,141.30M | 3,100.10M | 3,104.40M | 3,598.60M | 3,423.40M | 3,580.90M | 3,508.60M | 3,661.00M | 3,944.30M | 3,566.60M | 3,667.00M | 4,425.10M | 4,368.40M | 5,107.70M | 5,530.60M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Leases | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Debt | 1,979.60M | 1,980.00M | 1,980.40M | 1,980.70M | 1,981.10M | 1,981.40M | 1,981.80M | 1,982.20M | 1,982.60M | 1,982.90M | 1,983.30M | 1,983.60M | 1,984.00M | 1,984.40M | 1,984.80M | 1,985.10M | 1,986.00M | 1,986.00M | 1,986.20M | 1,987.00M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Convertible Debt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 56.50M | 73.30M | 33.50M | 58.70M | 60.10M | 69.80M | 85.50M | 116.20M | 125.30M | 126.70M | 185.80M | 205.60M | 207.40M | 185.70M | 211.80M | 206.30M | 219.20M | 208.70M | 225.10M | 220.40M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other Non-Current Liabilities | 662.60M | 680.20M | 692.50M | 724.70M | 598.60M | 638.00M | 677.30M | 716.80M | 832.40M | 854.10M | 908.50M | 1,463.20M | 1,543.60M | 1,571.40M | 1,674.40M | 1,701.90M | 1,861.80M | 2,018.80M | 2,126.20M | 2,281.60M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Non-Current Liabilities | 5,750.90M | 5,985.80M | 5,741.50M | 5,793.30M | 5,640.40M | 5,912.50M | 5,887.40M | 5,922.80M | 6,426.50M | 6,253.00M | 6,470.00M | 6,417.80M | 6,572.40M | 6,834.40M | 6,483.20M | 6,578.40M | 7,349.80M | 7,283.00M | 7,319.00M | 7,737.60M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | 6,413.50M | 6,666.00M | 6,434.00M | 6,518.00M | 6,239.00M | 6,550.50M | 6,564.70M | 6,639.60M | 7,258.90M | 7,107.10M | 7,378.50M | 7,881.00M | 8,116.00M | 8,405.80M | 8,157.60M | 8,280.30M | 9,211.60M | 9,301.80M | 9,445.20M | 10,019.20M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Debt | 1,979.60M | 1,980.00M | 1,980.40M | 1,980.70M | 1,981.10M | 1,981.40M | 1,981.80M | 1,982.20M | 1,982.60M | 1,982.90M | 1,983.30M | 1,983.60M | 1,984.00M | 1,984.40M | 1,984.80M | 1,985.10M | 1,986.00M | 1,986.00M | 1,986.20M | 1,987.00M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Common Equity | 17,258.00M | 18,768.80M | 19,914.70M | 20,687.80M | 21,438.80M | 22,664.00M | 23,495.20M | 24,017.90M | 24,904.40M | 25,973.10M | 26,991.10M | 28,205.80M | 29,325.90M | 29,353.60M | 29,387.60M | 29,938.90M | 30,957.80M | 31,256.90M | 31,423.60M | 31,711.40M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities and Shareholders Equity | 23,671.50M | 25,434.80M | 26,348.70M | 27,205.80M | 27,677.80M | 29,214.50M | 30,059.90M | 30,657.50M | 32,163.30M | 33,080.20M | 34,369.60M | 36,086.80M | 37,441.90M | 37,759.40M | 37,545.20M | 38,219.20M | 40,169.40M | 40,558.70M | 40,868.80M | 41,730.60M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury Shares | 17.93M | 19.40M | 19.94M | 20.60M | 22.00M | 22.60M | 23.50M | 24.50M | 25.10M | 25.50M | 25.80M | 26.40M | 27.00M | 28.20M | 29.70M | 31.60M | 32.70M | 33.70M | 34.70M | 36.40M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Retained Earnings | 16,739.30M | 18,968.30M | 19,941.80M | 20,793.90M | 22,109.60M | 23,306.70M | 24,124.50M | 25,092.90M | 26,100.70M | 27,260.30M | 27,982.30M | 29,414.60M | 30,755.20M | 31,672.90M | 32,384.40M | 33,680.20M | 35,045.80M | 35,797.10M | 36,423.80M | 37,621.40M | |||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Shares |
Pull Regeneron Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=REGN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "REGN", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=REGN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();